Cite
HARVARD Citation
Li, J. et al. (n.d.). Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet oncology. 16 (6), pp. 619-629. [Online].